Gender differences in vaccine therapy: where are we in COVID-19 pandemic?
In conclusion, it is apparent that the design of vaccines and vaccine strategies should be sex-specific, to reduce adverse reactions in females and increase immunogenicity in males. It should be mandatory to examine sex-related variables in pre-clinical and clinical vaccine trials, such as their crucial role for successful prevention of pandemic COVID-19.PMID:33840183 | DOI:10.4081/monaldi.2021.1669
Source: Monaldi Archives for Chest Disease - Category: Respiratory Medicine Authors: Tiziana Ciarambino Elena Barbagelata Graziamaria Corbi Immacolata Ambrosino Cecilia Politi Franco Lavalle Anna Ruggieri Annamaria Moretti Source Type: research
More News: Children | Clinical Trials | COVID-19 | Infectious Diseases | International Medicine & Public Health | Men | Menopause | Pandemics | Pregnancy | Respiratory Medicine | SARS | Study | Vaccines | Women